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Abstract
Background: Early lifestyle intervention with overweight and obese adolescents could help to avoid serious health
events in early adulthood, ultimately alleviating some of the strain on the public health system due to obesity-related
morbidity. Commercial weight loss programs have wide reach into the community setting, and have demonstrated
success in long term weight management in adults, beyond that of current public health care. Commercial
weight-management programs have not been evaluated as a method of delivery for overweight and obese
adolescents. This study aims to evaluate the efficacy of a new adolescent weight management program in a commercial
environment.
Methods: One hundred and forty adolescents, 13 to 17 years old, will be randomised to either a weight
management program intervention or a wait-listed group for 12 weeks. The commercial program will consist of
a combined dietary and lifestyle approach targeting improved health behaviours for weight-loss or weight-stability.
Participants will be overweight or obese (above the 85th percentile for BMI) and without existing co-morbidities.
Outcome measures will be assessed at baseline and after 12 weeks. Primary outcome measures will be changes
in BMI Z-score and waist-height ratio. Secondary outcome measures will include changes in behaviour, physical
activity and psychosocial wellbeing. Intervention participants will be followed up at 6 months following completion of
the initial program. Ethics approval has been granted from the Monash University Human Research Ethics Committee
(CF11/3687–2011001940).
Discussion: This independent evaluation of a weight management program for adolescents, delivered in a commercial
setting, will provide initial evidence for the effectiveness of such programs; which may offer adolescents an avenue of
weight-management with ongoing support prior to the development of obesity related co-morbidities.
Trial registration: The protocol for this study is registered with the International Clinical Trials Registry ISRCTN13602313.
Keywords: Adolescent, Commercial weight management, Obesity
Background
Australian prevalence of overweight and obesity in
childhood and adolescence increased from 20.9 % in
1995 to 24.7 % in 2008 [1]. While the trend has started
to stabilise, a significant proportion (25.7 % in 2012) of
Australian children and adolescents aged 5 to 17 years,
remain overweight or obese [1]. Within sub-populations
the prevalence can be even higher, for example 31 % of
children living in lower socioeconomic status (SES) areas,
including rural areas are overweight or obese compared to
18 % of those living in the highest SES areas [2].
Overweight and obese adolescents are more likely to
become overweight and obese adults than healthy weight
adolescents [3]. Additionally, obesity-related cardiovas-
cular disease (CVD) risk markers present in adolescence
are predictive of adult, obesity related morbidity [4]. A
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study in Denmark observed that every 1 unit increase in
body mass index (BMI) Z-score from age 7 to 13 years
in boys and 10 to 13 years in girls, significantly increases
the risk of a cardiovascular event in adulthood [5]. A
2001 Australian report suggested that interventions that
result in as little as 5 kg weight loss in all overweight
and obese individuals could lower the total prevalence of
overweight and obesity by 15 % [6]. Thus, adolescent
weight management is a significant, modifiable risk fac-
tor for the development of cardiovascular morbidity that
could lead to premature mortality in adult life [7–9].
There have been two Cochrane reviews of childhood
obesity management. The 2009 Cochrane Review con-
sidered interventions for treating obesity in children. It
included a total of six weight-loss dietary interven-
tion studies (n = 350 participants across age ranges)
demonstrating overall beneficial effects of weight-loss
on adiposity and BMI Z-score [10]. Twelve physical
activity intervention studies were also included, which
generally reported no significant change in BMI Z-score
or adiposity [10]. Meta-analyses of lifestyle interventions
demonstrated a favourable effect on BMI Z-score at
6 months [mean difference (MD) = -0.06 (95 % CI -0.12,–
0.01)] in children aged less than 12 years, and in those
over 12 years of age [MD-0.14 (95 % CI-0.17,–0.12)].
Parental involvement was noted to be an ingredient for
successful intervention. However, the report highlighted
the scarcity of studies in the adolescent age range.
The more recent 2011 Cochrane Review focused on
interventions for preventing obesity in children and used
BMI Z-score as a key outcome measure. The Review
demonstrated the very different effects of weight man-
agement programs in children compared to adults, with
data being abstracted and grouped by age rather than by
intervention type. Most new studies included in 2011
were obesity prevention studies in children, the majority
of which took place in schools. In the adolescent age
group (13 to 18 years), analysis of ten studies demon-
strated an overall BMI change of -0.09 kg/m2 (95 % CI-
0.20, 0.03) [11]. However a high level of heterogeneity
between studies was observed potentially due to incon-
sistent levels adiposity across studies as different cut-offs
and anthropometric measures were applied. Further, the
authors stressed an increasing awareness of the need for
weight loss maintenance, and recommended that future
studies monitor the effectiveness of programs in the
longer-term [11].
A retrospective study that examined the long term ef-
fects of a weight management program for individuals
(aged 1 to 18 years), delivered by physicians and dieti-
tians in a primary care setting, demonstrated significant
reductions in BMI Z-score [MD-0.16 (95 % CI not
reported)], and participants subsequently showed improve-
ments in several CVD risk factors such as LDL-cholesterol
(p = 0.02), 2 h plasma glucose (p = 0.004) and peak insulin
levels (p = 0.04) after a 2 year period [12]. Those who
attended sessions more frequently exhibited better results.
Improved blood pressure has also been observed in chil-
dren and adolescents (aged 7 to 15 years) 2 years following
an intensive 3-month dietary intervention with a strong
follow-up program, that reduced BMI Z-score by-0.16
(95 % CI-0.22,–0.09) at 3 months [13].
Whilst programs delivered within primary care set-
tings are modestly successful, publicly funded health sys-
tems in Australia tend to only accommodate individuals
with existing obesity-related comorbidities. There are
few treatment options for overweight and obese adoles-
cents without complications. Early behavioural interven-
tion targeted at reducing weight with longer-term
maintenance could help reduce the numbers of young
patients presenting to the public health system with
serious weight-related health events. Evidence suggests
obese young people who successfully lose weight do not
have obvious complications arising from their obesity,
such as insulin resistance [14].
Randomised controlled trials have demonstrated the
superiority of commercially delivered programs for
weight management in adults, when compared with
usual care through the health service system [15–17].
Commercial weight loss programs are successful in initi-
ating and maintaining long term weight loss in adults
[18] and may also be a successful setting for weight
management adolescents. Collaboration between com-
mercial organisations and primary care facilities may be
an efficacious strategy to deliver weight management
programs on a large scale [19]. Commercial weight man-
agement programs can offer ongoing, long term support
that cannot be provided by health professionals in
primary care and has a wide reach including rural
areas and they have the ability to be accessible to in-
dividuals within the population that are unable to ac-
cess primary medical services for weight management
[20]. Despite evidence for the benefits from an inten-
sive multifactorial approach to weight-management in
adolescents [10, 11, 21], no study to date has exam-
ined commercially available and delivered weight man-
agement programs specifically tailored to the needs of
adolescents.
Jenny Craig Weightloss Centres Pty Ltd, has developed
a new 12-week adolescent weight management program,
‘JenMe’. The program involves weekly face to face ses-
sions with a Jenny Craig-trained consultant that includes
dietary and behavioural education as well as monitoring
of the progress of the adolescents. Menus and foods are
provided initially, with support for the adolescent to
eventually develop skills in their own menu planning.
On completion of the 12 week program on-going sup-
port is available that can be tailored to the individual’s
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needs. The program has not yet been evaluated for effi-
cacy, an essential first step in supporting the claim of an
evidence-based approach to weight management in
young people. This study aims to address this gap.
We propose to evaluate a commercially delivered ado-
lescent weight management program ‘JenMe’; for effi-
cacy. We know that lifestyle interventions for children
are effective in the short term but there are few studies
that examine the long term prognosis of short term
weight loss and the ability of adolescents to maintain
that weight loss over time. Data from the 6-month diet
and lifestyle ‘Eat Smart’ intervention for Australian ado-
lescents compared favourably with previously published
data (BMI Z-score MD-0.12 (SD 0.10) at 3 months) [10],
but early follow up data have already began to show a
plateau in weight loss followed by some weight re-gain.
Hence, the current study proposes to follow intervention
participant weight management for 6 months after com-
pletion of the 12 week program.
This study will be the first to assess an adolescent
weight management program that is conducted in a
commercial environment. Its findings will inform the
literature in the field of adolescent weight-loss and man-
agement, and has the potential to unveil an effective
solution to adolescents seeking weight management in a
community setting.
Methods
Study design and participants
The current study is a multicentre, parallel-group
randomised controlled trial. Adolescent boys and girls
aged 13 to 17 years who apply to join the commercial
weight management program will be screened for eligi-
bility to participate. Individuals who do not meet the
health screen requirement, a standard practice for en-
rolment to Jenny Craig weight management programs,
will not be eligible for inclusion in the study. Exclusion
criteria of the program include being aged less than
13 years or greater than 17 years; having diagnosed dia-
betes; being pregnant; having given birth to a child dur-
ing adolescence; having a medical condition or using
medications related to weight co-morbidities (except
asthma). Individuals who have a BMI Z-score of ≥
1.282, indicating that they are above the 85th percentile
for BMI for their age and gender, will be invited to par-
ticipate in the study. Participants will be randomised
into either the treatment group or the wait-listed con-
trol group. The treatment group will enter the weight
management program immediately, and the control
group will be wait-listed for 12 weeks. Figure 1 shows
the study flow. Behavioural questionnaires and diaries
will be completed during the week prior to the first
consultation where anthropometric characteristics of
participants will be recorded. The same questionnaires
and diaries will be repeated during week 12 (the final
week of the program for participants in the interven-
tions group), and participants will again have anthropo-
metric characteristics recorded at the end of week 12.
Primary outcome measures will include changes in
BMI Z-score and waist to height ratio. Secondary out-
come measures will include changes in physical activity
levels, behaviour and psychosocial wellbeing. Partici-
pants will have the option to volunteer to have further
cardio-metabolic risk factors and body composition
examined. All experimental procedures are being con-
ducted in accordance with the Declaration of Helsinki
and were formally approved by the Monash University
Human Research Ethics Committee (CF11/3687–
2011001940).
Sample size calculations
For the purpose of sample size estimation, the primary
outcome of this study was difference in BMI Z-score at
12 weeks. Our own pilot data, and data from the largest
RCT in obese adolescents yet published (209 children
aged 8-16 with BMI > 95th percentile; Savoye 2007) sug-
gest the standard deviation in BMI Z-score in a non-
passive weight loss intervention will be approximately
0.27. Assuming a 2-sided 0.05 significance level, a sam-
ple size of 52 participants per group would provide
80 % power to detect a clinically important treatment
difference of 0.15 BMI Z-score. To account for a 25 %
drop-out, we plan to enrol 70 participants in each
group.
Fig. 1 Study flow design. One hundred and forty adolescents
(13 to 17 years, BMI Z-score≥ 1.282) will be recruited and randomised
1:1 to either the intervention or wait-listed control group. The
intervention group will receive a 12 week commercial weight
management program. The wait-listed control group will be offered
the program after the control period (12 weeks)
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Recruitment and randomisation
The study will be advertised within the weight manage-
ment centres in Victoria, Western Australia, New South
Wales and the Australian Capital Territory as well as on
the company website. Potentially eligible clients will be
assessed in the weight management centres by consul-
tants, guided by dietitians and/or a general practitioner
for study eligibility. If participants who meet eligibility
criteria are interested in participating in the study, they
will be shown an information DVD. All participants will
provide written consent that will be obtained by consul-
tants in the weight loss centres from both the adolescent
and their parent or guardian. Consenting adolescents
will then be recruited into the study via telephone by a
researcher.
Allocation to treatment group (intervention or wait-
listed control) will occur using computer-generated ran-
dom numbers. Group allocation will occur off-site by a
statistician with no day-to-day study involvement in the
trial. Individuals will be allocated 1:1 to the intervention
group or wait-listed. Randomisation of the study partici-
pants will be stratified by the weight-management centre
from which they are enrolled. Within each centre, ran-
domisation will occur in blocks of either 6 or 8. Block
size will be randomly selected and unknown to anyone
except the study statistician (RSW). Treatment alloca-
tion will be stored in an online database, accessible only
by the study statistician, and will remain unknown until
revealed to the study co-ordinator on the day each par-
ticipant is allocated to a treatment group. Due to the na-
ture of the intervention masking participants to group
allocation is not possible.
Intervention: the JenMe program
A 12 week evidence-based lifestyle intervention program
was developed by the team of Accredited Practising
Dietitians at Jenny Craig Australia and was reviewed for
content by paediatric psychologists specialising in behav-
iour change. The program will be delivered face to face
to clients in the Jenny Craig Centres by consultants on a
weekly basis for the duration of the program. Consul-
tants in the centres have been trained by Jenny Craig
and are not otherwise required to be trained health pro-
fessionals. Specialised program materials will be used
with participants and their parents or guardians. The
participants will present to the centre to meet with a
consultant weekly for 13 consecutive weeks (Weeks 0 to
12). Each week, a new element of the program (Table 1)
will be delivered at each consultation to the adolescent,
who will be encouraged to modify small behaviours each
week. The order of topic deliverance will be directed by
the adolescent and tailored to their needs. The parent or
guardian will be involved in part of the consultation to
ensure participation in the goal setting process. The
program also encompasses a dietary plan that has been
modelled on the dietary guidelines as outlined by the
National Health and Medical Research Council’s
(NHMRC, 2013) Australian Dietary Guidelines [22].
Initially the participant will follow the menu that
includes pre-packaged food provided by the commercial
program, combined with their own grocery items.
Throughout the program the adolescent, with the sup-
port of their consultant and parent or guardian will learn
how to plan their own menus using all of their own
foods, and either during or following the 12 week pro-
gram, they will eventually transition onto their own
menu planning (Table 1). In accordance with usual prac-
tice at Jenny Craig, once the 12 week ‘JenMe’ program is
complete, adolescents have the option to receive on-
going, individually-tailored support, depending on the
need for further weight-loss or weight-maintenance up
to the age of 18 years of age as part of their Jenny Craig
membership. Also, as with any commercial program,
participants are free to withdraw from the program at
any stage, for any reason.
Wait-listed control
The wait-listed control group will receive standard
healthy eating guidelines, the ‘Healthy Eating for
Children’ booklet developed by the National Health and
Medical Research Council based on the Australian
Dietary Guidelines [22], and advised to maintain their
current lifestyle habits for the control period. Wait-listed
control participants will be offered the commercial
weight management program at the end of the control
period (12 weeks).
All study participants, from both the intervention and
control groups will receive a free adolescent membership
with Jenny Craig, which is valid until they are 18 years
of age as well as a discount on all Jenny Craig food
provisions for 12 months.
Outcomes
Anthropometry
All participants will have their baseline weight, height,
waist, and body composition (using bioelectric imped-
ance analysis (BIA); BODYSTAT Quad Scan 4000,
BODYSTAT Ltd., Douglas, Isle of Man, UK) measured
by trained Jenny Craig consulting staff using standard
operating procedures. BMI Z-score will be calculated by
the lambda-mu-sigma (LMS) method using Centre for
Disease Control reference data (http://www.cdc.gov/
growthcharts/percentile_data_files.htm) which takes into
account age and gender. Participants will be required to
self-assess their pubertal status using the Tanner stages
of puberty scale [23, 24]. The intervention group will
have weekly weight measurements, height measured
every 4 weeks and waist and body composition assessed
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by BIA measured at 0 and 12 weeks. Wait-listed control
participants will have all measurements taken at 0 and
12 weeks only.
Dietary analysis
Intervention and wait-listed control participants will be
required to complete a 4-day food diary, both in the
week prior to commencement of the intervention or
wait-listed period and again at 12 weeks. Dietary analysis
of energy and nutrient intake will be performed using
Foodworks 7 (Xyris Software Pty Ltd., QLD, Australia).
Foodworks will be supplemented with food composition
data of the pre-packaged foods supplied by the commer-
cial weight-management company for assessment of
intervention participants’ week 12 energy and micronu-
trient intake.
Physical activity
In order to monitor physical activity levels, the adoles-
cents in both groups will be required to complete the
Adolescent Physical Activity Recall Questionnaire
(APARQ), which has been validated in an Australian
population [25]; and complete a 4-day activity diary
(Children’s Nutrition Centre, University of Queensland,
Australia). A pedometer will be worn over the 4- day
period and number of steps will be recorded in the activ-
ity diary. This will be performed both in the week prior
to commencement of the intervention or wait-listed
period and repeated at 12 weeks.
Participant attitudes to eating, self-image and quality of life
Questionnaires will be completed by both groups both
in the week prior to commencement in the study and
again at week 12 of the intervention or wait-listed
period. The questionnaires will be used to assess the im-
pact of the program on psychosocial factors and also the
relationship between baseline psychosocial factors and
primary outcomes. General and body specific self-esteem
will be assessed via the Rosenberg 5-item self-esteem
scale questionnaire [26], and the Mendelson & White
24-item body-esteem questionnaire [27].
The Eating Attitudes Test (EAT)-26 [28] will be used
to measure symptoms and concerns characteristic of
eating disorders. The items on this scale will be summed
to form three subscales; Dieting, Bulimia and Food
Preoccupation and Oral Control.
The Strengths and Difficulties Questionnaire (SDQ)
adolescent version report will be used to measure ado-
lescent behaviours, emotions and relationships [29]. The
items on this scale will be summed to form five subscales;
Emotional Symptoms, Conduct Problems, Hyperactivity,
Peer Problems, and Pro-social Behaviour.
The Impact of Weight on Quality of Life-KIDS
(IWQOL-Kids) will be used to measure obesity specific
health related quality of life [30]. The items on this scale
will be summed to form four subscales; Physical Comfort,
Body Esteem, Social Life, Family Relations.
The 12-item multidimensional perceived social sup-
port questionnaire will also be completed to assess three
sources of perceived support: family, friends, and signifi-
cant other [31].
These measures have been validated for use with
children and adolescents [26–28, 30, 32–34].
Parental involvement
Parents and guardians will be required to complete the
Strengths and Difficulties Questionnaire (SDQ) parent
version report, a measure of adolescent behaviours,
emotions and relationships (Subscales; Emotional Symp-
toms, Conduct Problems, Hyperactivity, Peer Problems,
and Prosocial Behaviour) [29] and a demographic ques-
tionnaire prior to their adolescent’s commencement in
the study and the SDQ will be repeated during week 12
of the intervention or wait-listed period.
Metabolic markers
Participants from both groups will be able to volunteer
for further metabolic testing. A subset of participants
will opt-in to provide a fasting blood sample at 0 and
12 weeks for the assessment of metabolic markers. Blood
will be collected in EDTA containing blood tubes
(McFarlane Medical & Scientific, NSW, Australia) and
Table 1 Topics covered over 12 weeks within the JenMe program
Eat Well Move more Live life
▪ Decoding drinks ▪ How to move more by tracking how you
move less
▪ Body image
▪ Eating out for success ▪ Overcoming your activity barriers ▪ Learning from lapses
▪ Jenny at school & friends’ ▪ Setting SMART goals ▪ Rewards & buddies
▪ Meals with the family and fast & healthy after school snacks ▪ Time for a physical activity challenge! ▪ Saying No
▪ Non-hungry eating & learning to eat with awareness
Independent menu planning
Getting started on your own 1. Your own menu guide 2. Working out grocery serves of recipes 3. Working out grocery serves of packaged
foods from labels
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immediately centrifuged at 2000 x g for 15 min at 4 °C.
Samples will be stored at-80 °C until analysis.
Glucose, cholesterol and triacylglycerol (TAG) concen-
trations in plasma will be measured on a Roche Cobas
Integra 400 plus auto-analyser (Roche, Lavel, Quebec,
Canada) by enzymatic colorimetric methods using com-
mercially available kits (CHOL2, TRIGL and Glucose
HK Gen 3) as per the manufacturer’s instructions (Roche,
Lavel, Quebec, Canada).
Plasma insulin will be determined using the Human
Insulin Specific RIA kit HI–14 K (Merck Millipore,
Billerica, MA, USA) according to manufacturer’s instruc-
tions and read on a Gamma Counter.
Body composition using dual energy x-ray
absorptiometry (DXA)
Participants from both groups will be able to volunteer
for further body composition assessment. A subset of
individuals will opt-in to participate in a whole body
DXA scan for body composition at 0, 12 and 36 weeks
(intervention only). Participants will attend the labora-
tory and have their height and weight measured, using
standard operating procedures, to determine the correct
amount of radiation required for the whole body scan.
Whole body composition will be estimated with a GE
LUNAR iDEXA Narrow-Angle Dual Energy X-Ray
Densitometer with SmartFAN™ (GE Medical, Software
Lunar DPX enCORE 2012 version 14.0, Madison, WI).
Follow-up
All outcome measures will be assessed in the interven-
tion participants at a follow-up at 36 weeks after com-
mencement in the program (6 months after program
completion), in order to track longer-term weight man-
agement. It will not be possible to follow-up the wait-
listed participants as a control group as they will have
the option to commence the program at end of their
12-week wait-listed period.
Statistical analysis plan
Summary descriptive statistics for demographic and clin-
ical data at baseline will be reported by allocated study
treatment. Continuous data will be summarised descrip-
tively using either mean and standard deviation, or
median and inter-quartile range, depending on the dis-
tribution of the variable of interest. Categorical data will
be presented as frequencies and percentages. Compari-
sons between the treatment groups will be conducted to
assess the degree to which comparability of randomisa-
tion was achieved.
The primary study outcomes are between-group differ-
ences in age and gender adjusted BMI Z-score and
waist-to-height ratio at 12 weeks. The mean difference
between treatment groups will be calculated using linear
regression with treatment group entered as the main
effect and covariable adjustment for baseline outcome.
The corresponding 95 % Wald confidence interval and
p-value will be reported. For secondary outcomes, the
effect estimate relating to a variable with a binary out-
come will be presented as an odds ratio, which will be
calculated using a logistic regression model. The effect
estimate relating to a variable with a continuous out-
come will be presented as a mean difference, which will
be calculated using a linear regression model. The effect
estimate relating to a variable with a count outcome will
be presented as an incident rate ratio, which will be cal-
culated using a Poisson regression model. For all models
considering outcomes measured at 12 weeks, the base-
line outcome will be included as a covariable. For all
models the corresponding 95 % Wald confidence inter-
val and p-value will be reported.
The initial approach to all analyses will be based on
the ‘intention to-treat’ (ITT) principle, where all evalu-
able data is analysed in the treatment group according
to which the participant was allocated. Additionally, be-
cause of the potential for differential between-group at-
trition due to the nature of recruitment, all analyses will
be investigated to see whether results are sensitive to
possible between-group imbalances in key demographic,
social, or clinical characteristics. Characteristics of par-
ticipants for whom follow-up data is available will be
compared between groups, and variables significantly
different at P < 0.05 will be identified. Multivariable re-
gression models will be run with treatment group as the
main effect and covariables including the value of the
outcome at baseline and characteristics identified as dif-
fering between treatment groups at follow-up. All sensi-
tivity analyses will be clearly labelled., Statistical
significance will be defined as alpha = 0.05. All tests
conducted will be two-tailed.
Outcomes measured at six months will be analysed
using mixed-effects regression models with a random
intercept for each participant. For continuous outcomes
Gaussian family and identity link function, for binary
outcomes a binomial family and logit link function, and
for count outcomes a Poisson family and log link func-
tion will be used. All models will include time period
(baseline/12 weeks/36 weeks) as a main effect, and other
covariables will be included as appropriate.
Ethics and dissemination
It has previously been demonstrated that children ran-
domised to wait-listed or only given written information
(control groups) gain weight [35]. Allocating overweight
and obese children to be wait-listed for 12 weeks raises
ethical concern as weight gain in children that are not
treated could be disadvantaged, particularly with chil-
dren that have identified their need for weight-loss
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assistance in a community setting. In the current study, as
participants will not have weight-related co-morbidities,
ethical permission has been approved to delay treatment in
a wait-listed control group for 12 weeks after which they
will have the opportunity to undertake the commercially
available weight management program. Participants have
the right to withdraw from the study at any time, for any
reason. If a wait-listed control participant chooses to com-
mence the program immediately, it will be made available
to them, but they will not participate in the study. Ethical
approval for the study has been granted by Monash
University Human Research Ethics Committee (approval
no: CF11/3687–2011001940).
Discussion
Tailored weight management strategies are needed to re-
duce the growing prevalence of adolescent overweight
and obesity, and consequent burden of disease in young
people. However, interventions must be delivered with
care to avoid the promotion of harmful teenage dieting
and take precautions to ‘do no harm’. Body image is an
highly ranked concern among Australian adolescents
[36]. Concerns over body image have been linked to
engagement in dieting behaviours that can lead to disor-
dered eating [37]. A USA study showed that of 2287
surveyed adolescents 61 % of girls and 28 % of boys had
engaged in unhealthy weight-loss behaviours [38]. Fur-
thermore, the incidence of these behaviours has been
observed to increase with age [39]. The JenMe adoles-
cent program is designed to engage and educate adoles-
cents using evidence-based principles for healthy eating
and activity behaviours, rather than promote dieting
with unhealthy weight-management outcomes. The vali-
dated questionnaires that are being used to assess the
safety and efficacy of the program are designed to evalu-
ate whether the program can nurture positive outcomes
rather than facilitate harmful behaviours.
Commercial programs are currently available within
the community and have demonstrated to be successful
in an adult population [15, 17]. Such programs have the
resources to provide ongoing, long term support that is
not always provided by health professionals in primary
care due to restraints on time and patient load [20]. This
study is designed to determine whether a multi-faceted,
commercial weight management program, delivered in a
community setting will be a useful resource for over-
weight and obese adolescents.
This study will observe changes in body measures
including BMI Z-score and waist to height ratio, and
outcomes such as quality of life, in order to thoroughly
assess the efficacy and safety of the program.
Competing interests
In the past five years HT and MB have received research funding from Jenny
Craig Weightloss Centres Pty Ltd.
Authors’ contributions
AD drafted the manuscript, will manage the trial from Monash University
and will compile all the data.
MB conceived the trial and participated in its design and co-ordination and
helped to draft the manuscript; RW designed the and wrote the statistical
analysis plan and helped to draft the manuscript; LB consulted on the use of
behavioural questionnaires and analysis and helped to draft the manuscript;
HT conceived the trial and participated in its design and co-ordination and
helped to draft the manuscript. All authors read and approved the final
manuscript.
Authors’ information
RW-statistician, LB-clinical, health, educational and developmental psychologist,
HT-paediatric dietitian.
Acknowledgements
The authors would like to acknowledge Alison Evans for her assistance in
setting up the DXA facility and training staff at the Department of Nutrition
and Dietetics, Monash University.
Funding
This study is supported by Jenny Craig Weightloss Centres Pty Ltd., a
commercial organisation, which will provide program activities and materials.
Pre-packaged food will be provided by Jenny Craig at a discount to study
participants. Funding will be provided through a clinical trial contract to the
coordinating centre (Department of Nutrition & Dietetics, Monash University,
Notting Hill).
Jenny Craig had minimal role in the design and protocol development for
the evaluation of the program. By contractual agreement, scientists at
Monash University and other participating institutions have responsibility
and independence regarding data management, analysis and publication.
Author details
1Department of Nutrition & Dietetics, Monash University, Level 1, 264
Ferntree Gully Rd, Notting Hill, VIC 3168, Australia. 2UQ Child Health Research
Centre, School of Medicine, The University of Queensland, QLD 4006,
Australia. 3School of Population Health, The University of Queensland, QLD
4006, Australia. 4School of Psychology, Australian Catholic University, VIC
3065, Australia.
Received: 14 November 2014 Accepted: 10 June 2015
References
1. ABS: Australian Bureau of Statistics. Australian health survey, updated results
2011-2012, vol. 2013. Canberra: Australian Bureau of Statistics; 2013.
2. AIHW, AIHW: Australian Institute of Health & Welfare. Headline indicators for
children's health, development and wellbeing, vol. 2011. Canberra:
Australian Institute of Health & Welfare; 2011.
3. Patton GC, Coffey C, Carlin JB, Sawyer SM, Williams J, Olsson CA, et al.
Overweight and obesity between adolescence and young adulthood: a
10-year prospective cohort study. J Adolesc Health. 2011;48(3):275–80.
4. Freedman DS, Dietz WH, Srinivasan SR, Berenson GS. The relation of
overweight to cardiovascular risk factors among children and adolescents:
the Bogalusa heart study. Pediatrics. 1999;103(6):1175–82.
5. Baker JL, Olsen LW, Sorensen TIA. Childhood body-mass index and the risk
of coronary heart disease in adulthood. N Engl J Med. 2007;357(23):2329–37.
6. Marks G, Coyne C, Pang G. Type 2 diabetes costs in Australia - the potential
impact of changes in diet, physical activity and levels of obesity. In: Brisbane:
Australian Food and Nutrition Modelling Unit: Commenwealth Department of
Health & Aged Care. Canberra: Commonwealth Department of Health and
Ageing, 2001.
7. Masquio DC, de Piano A, Sanches PL, Corgosinho FC, Campos RM, Carnier J,
et al. The effect of weight loss magnitude on pro-/anti-inflammatory
adipokines and carotid intima-media thickness in obese adolescents
engaged in interdisciplinary weight loss therapy. Clin Endocrinol (Oxf).
2013;79(1):55–64.
8. Abrams P, Levitt Katz LE, Moore RH, Xanthopoulos MS, Bishop-Gilyard CT,
Wadden TA, et al. Threshold for improvement in insulin sensitivity
with adolescent weight loss. J Pediatr. 2013;163(3):785–90.
Dordevic et al. BMC Public Health  (2015) 15:563 Page 7 of 8
9. Juonala M, Magnussen CG, Berenson GS, Venn A, Burns TL, Sabin MA, et al.
Childhood adiposity, adult adiposity, and cardiovascular risk factors. N Engl J
Med. 2011;365(20):1876–85.
10. Oude Luttikhuis H, Baur L, Jansen H, Shrewsbury VA, O’Malley C, Stolk RP,
et al. Interventions for treating obesity in children. Cochrane Database Syst
Rev. 2009;1:CD001872.
11. Waters E, de Silva-Sanigorski A, Hall BJ, Brown T, Campbell KJ, Gao Y, et al.
Interventions for preventing obesity in children. Cochrane Database Syst
Rev. 2011;12:CD001871.
12. Kubicky RA, Dunne C, Nandi-Munshi D, De Luca F. Long-term effects of a
non-intensive weight program on body mass index and metabolic
abnormalities of obese children and adolescents. Int J Pediatr Endocrinol.
2012;2012:16.
13. Mirza NM, Palmer MG, Sinclair KB, McCarter R, He J, Ebbeling CB, et al.
Effects of a low glycemic load or a low-fat dietary intervention on body
weight in obese Hispanic American children and adolescents: a randomized
controlled trial. Am J Clin Nutr. 2013;97(2):276–85.
14. Baxter KA, Ware RS, Batch JA, Truby H. Predicting success: factors associated
with weight change in obese youth undertaking a weight management
program. Obes Res Clin Pract. 2013;7(2):e147–54.
15. Jolly K, Lewis A, Beach J, Denley J, Adab P, Deeks JJ, et al. Comparison of
range of commercial or primary care led weight reduction programmes
with minimal intervention control for weight loss in obesity: Lighten up
randomised controlled trial. BMJ. 2011;343:d6500.
16. Truby H, Bonham M. What makes a weight loss programme successful?
BMJ. 2011;343:d6629.
17. Rock CL, Flatt SW, Sherwood NE, Karanja N, Pakiz B, Thomson CA. Effect of a
free prepared meal and incentivized weight loss program on weight loss
and weight loss maintenance in obese and overweight women: a
randomized controlled trial. JAMA. 2010;304(16):1803–10.
18. Truby H, Baxter K, Elliott S, Warren J, Davies P, Batch J. Adolescents seeking
weight management: who is putting their hand up and what are they
looking for? J Paediatr Child Health. 2011;47(1-2):2–4.
19. Lavin JH, Avery A, Whitehead SM, Rees E, Parsons J, Bagnall T, et al.
Feasibility and benefits of implementing a slimming on referral service in
primary care using a commercial weight management partner. Public
Health. 2006;120(9):872–81.
20. WHO: World Health Organization. Obesity: preventing and managing the
global epidemic. Report of a WHO consultation (WHO technical report
series 894). Geneva: World Health Organization; 2000.
21. Ho M, Garnett SP, Baur LA, Burrows T, Stewart L, Neve M, et al. Impact of
dietary and exercise interventions on weight change and metabolic
outcomes in obese children and adolescents: a systematic review and
meta-analysis of randomized trials. JAMA Pediatr. 2013;167(8):759–68.
22. NHMRC. National Health & Medical Research Council. Australian dietary
guidelines. Canberra: National Health & Medical Research Council; 2013.
23. Marshall WA, Tanner JM. Variations in pattern of pubertal changes in girls.
Arch Dis Child. 1969;44(235):291–303.
24. Marshall WA, Tanner JM. Variations in the pattern of pubertal changes in
boys. Arch Dis Child. 1970;45(239):13–23.
25. Booth ML, Okely AD, Chey TN, Bauman A. The reliability and validity of the
adolescent physical activity recall questionnaire. Med Sci Sports Exerc.
2002;34(12):1986–95.
26. Simmons RG, Rosenberg F, Rosenberg M. Disturbance in the self-image at
adolescence. Am Sociol Rev. 1973;38(5):553–68.
27. Mendelson BK, White DR. Relation between body-esteem and self-esteem
of obese and normal children. Percept Mot Skills. 1982;54(3):899–905.
28. Garner DM, Olmsted MP, Bohr Y, Garfinkel PE. The eating attitudes test:
psychometric features and clinical correlates. Psychol Med. 1982;12(4):871–8.
29. Goodman R. The strengths and difficulties questionnaire: a research note.
J Child Psychol Psychiatry. 1997;38(5):581–6.
30. Kolotkin RL, Zeller M, Modi AC, Samsa GP, Quinlan NP, Yanovski JA, et al.
Assessing weight-related quality of life in adolescents. Obesity.
2006;14(3):448–57.
31. Zimet GD, Dahlem NW, Zimet SG, Farley GK. The multidimensional scale of
perceived social support. J Pers Assess. 1988;52(1):30–41.
32. Maiano C, Morin AJ, Lanfranchi MC, Therme P. The Eating Attitudes Test-26
revisited using exploratory structural equation modeling. J Abnorm Child
Psychol. 2013;41(5):775–88.
33. Johnson S, Hollis C, Marlow N, Simms V, Wolke D. Screening for childhood
mental health disorders using the Strengths and Difficulties Questionnaire:
the validity of multi-informant reports. Dev Med Child Neurol.
2014;56(5):453–9.
34. Zimet GD, Powell SS, Farley GK, Werkman S, Berkoff KA. Psychometric
characteristics of the Multidimensional Scale of Perceived Social Support.
J Pers Assess. 1990;55(3-4):610–7.
35. Wilfley DE, Tibbs TL, Van Buren DJ, Reach KP, Walker MS, Epstein LH.
Lifestyle interventions in the treatment of childhood overweight: a
meta-analytic review of randomized controlled trials. Health Psychol.
2007;26(5):521–32.
36. Mission Australia Youth Survey [https://www.missionaustralia.com.au/
what-we-do/research-evaluation/youth-survey]
37. Moore DC. Body image and eating behavior in adolescents. J Am Coll Nutr.
1993;12(5):505–10.
38. Neumark-Sztainer D, Wall M, Larson NI, Eisenberg ME, Loth K. Dieting and
disordered eating behaviors from adolescence to young adulthood:
findings from a 10-year longitudinal study. J Am Diet Assoc.
2011;111(7):1004–11.
39. Liechty JM, Lee MJ. Longitudinal predictors of dieting and disordered
eating among young adults in the U.S. Int J Eat Disord. 2013;46(8):790–800.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Dordevic et al. BMC Public Health  (2015) 15:563 Page 8 of 8
